ANA
DE LORENZO PINTO
Profesora asociada de Ciencias de la Salud
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (13)
2022
-
Comparison of a polypharmacy-based scale with Charlson comorbidity index to predict 6-month mortality in chronic complex patients after an ED visit
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1795-1803
-
Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis
JMIR mHealth and uHealth, Vol. 10, Núm. 4, pp. e29985
-
PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
Biomedicine and Pharmacotherapy, Vol. 146
2020
-
Promoting clinical pharmacy services through advanced medication review in the emergency department
European Journal of Hospital Pharmacy , Vol. 27, Núm. 2, pp. 73-77
2019
-
Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia
International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147
2018
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo
Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 825-831
-
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project
International Journal of Clinical Practice, Vol. 71, Núm. 8
-
Iniciativas para conseguir una atención excelente en el síndrome coronario agudo. Respuesta
Revista Espanola de Cardiologia
2016
-
Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration
Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 4, pp. 444-446
-
Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162
-
The challenges of the loading dose
Drugs and Therapy Perspectives, Vol. 32, Núm. 10, pp. 447-448
2014
-
Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes
International Journal of Clinical Pharmacy, Vol. 36, Núm. 4, pp. 821-826